Follow
Interview with Scandion Oncology
08 October 2020 - 11:32
Interview with Scandion Oncology CSO Nils Brünner during the cancer research day at Penser Bank....
We have reserved some of the more detailed information for our registered users. Please sign in if You have already registered.
Get access to Events, Instruments, Documents, Media and much more by signing up for FREE!
Scandion Oncology A/S
Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has s...
Learn more about company